Kotra Industries BhdXKLS:0002 84 Operating Margin % is 20.74% as of Mar. 2026, which is 34% above its 10-year median of 15.52. GuruFocus rates XKLS:0002 with a GF Score™ of 84/100 and a GF Value™ of RM4.33 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 955 Drug Manufacturers companies, Kotra Industries Bhd ranks better than 83.77% on this metric.
Kotra Industries Bhd operating margin is expanding. Margin expansion is usually a good sign.
The historical rank and industry rank for Kotra Industries Bhd's Operating Margin % or its related term are showing as below:
XKLS:0002'
s Operating Margin % Range Over the Past 10 Years
Min: 7.74 Med: 15.52 Max: 26.72
Current: 21.46
XKLS:0002's Operating Margin % is ranked better than 83.77% of 955
companies
in the Drug Manufacturers industry
Industry Median: 7.45
vs XKLS:0002: 21.46
Kotra Industries Bhd's 5-Year Average Operating Margin % Growth Rate was 7.80% per year.
Kotra Industries Bhd (XKLS:0002) Operating Margin % Explanation
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Kotra Industries Bhd Operating Margin % Related Terms
Kotra Industries Bhd Operating Margin % Historical Data
* Premium members only.
The historical data trend for Kotra Industries Bhd's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:0002 vs ZTS, UTHR, VTRS: Operating Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Kotra Industries Bhd's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kotra Industries Bhd Operating Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Kotra Industries Bhd's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Kotra Industries Bhd's Operating Margin % falls into.
Kotra Industries Bhd Operating Margin % Calculation
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
Kotra Industries Bhd's Operating Margin % for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kotra Industries Bhd (XKLS:0002) has a Operating Margin % of 20.74% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Kotra Industries Bhd and its competitors. This is 34% above median its historical median of 15.52. Over the past decade, Kotra Industries Bhd's Operating Margin % has ranged from 7.74 to 26.72. According to the industry distribution chart, Kotra Industries Bhd ranks #155 out of 955 companies in the Drug Manufacturers industry, placing it in the top 16.2%.
Is Kotra Industries Bhd's Operating Margin % too high?
Kotra Industries Bhd's current Operating Margin % of 20.74% is 34% above median its 10-year median of 15.52. Over the past 10 years, this metric has ranged from a low of 7.74 to a high of 26.72. The Drug Manufacturers industry median Operating Margin % is 7.45. Kotra Industries Bhd's value of 20.74% is 178.4% above this industry median. Based on the distribution chart, Kotra Industries Bhd ranks #155 out of 955 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Kotra Industries Bhd has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Kotra Industries Bhd's Operating Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Kotra Industries Bhd ranks #155 out of 955 companies for Operating Margin %. This places Kotra Industries Bhd in the top 16% of its industry — outperforming the majority of peers. The industry median Operating Margin % is 7.45. Kotra Industries Bhd's value of 20.74% is 178.4% above this benchmark. Historically, Kotra Industries Bhd's own Operating Margin % has ranged from 7.74 to 26.72 over the past decade. While the company's 10-year median is 15.52 vs. the industry median of 7.45, Kotra Industries Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Drug Manufacturers company?
The median Operating Margin % among Drug Manufacturers companies is 7.45, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kotra Industries Bhd's current Operating Margin % of 20.74% is 178.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Kotra Industries Bhd and its competitors. For the Drug Manufacturers industry, the median Operating Margin % is 7.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kotra Industries Bhd's current Operating Margin % is 20.74%, which is 34% above median its own 10-year median of 15.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kotra Industries Bhd stock overvalued right now?
Based on GuruFocus' analysis, Kotra Industries Bhd (XKLS:0002) is currently considered Modestly Undervalued. The stock's GF Value™ is RM4.33, compared to a current price of RM3.71 — trading 14.3% below its estimated fair value. The current Operating Margin % is 20.74%, which is 34% above median its 10-year median of 15.52 and 178.4% above the Drug Manufacturers industry median of 7.45. Kotra Industries Bhd's overall GF Score™ is 84/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Kotra Industries Bhd (XKLS:0002), the current Operating Margin % is 20.74% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kotra Industries Bhd (XKLS:0002) Overvalued in 2026?
Based on GuruFocus' analysis, Kotra Industries Bhd stock appears to be undervalued.
The current stock price of RM3.71 is trading 14.3% below its estimated GF Value™ of RM4.33.
GuruFocus considers Kotra Industries Bhd to be Modestly Undervalued.
Key valuation signals for XKLS:0002:
Operating Margin %: 20.74% (34% above median its 10-year median of 15.52)
GF Value™: RM4.33 vs. price of RM3.71 (14.3% below fair value)
Industry Position: 178.4% above the Drug Manufacturers median (#155 of 955)
No single metric tells the full story. See the XKLS:0002 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kotra Industries Bhd is a Malaysian pharmaceutical company engaged in the development, manufacturing, and supply of pharmaceutical and healthcare products supporting all life stages. Its portfolio includes life-saving medicines, OTC supplements, and nutrition products. The Group markets three core brands: Appeton, offering health supplements and nutrition across all age groups; Vaxcel, providing injectable medicines for infectious diseases, kidney care, and gastroenterology; and Axcel, specializing in oral and topical medicines for paediatrics, dermatology, and infectious diseases. The company operates in Malaysia and overseas, with the majority of revenue derived from Malaysia.
84GF Score
Get the complete analysis for XKLS:0002
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0002 has been successfully added to your 
